73 / 84
73
guided corticosteroid injection of the sacroiliac joint
in patients with spondyloarthropathy with
sacroiliitis: clinical outcome and followup by
dynamic magnetic resonance imaging. J Rheumatol
1996;23:659-64.
21. Bollow M, Braun J, Taupitz M, Häberle J,
Reibhauer BH, Paris S, et al. CT-guided
intraarticular corticosteroid injection into the
sacroiliac
joints
in
patients
with
spondyloarthropathy: indication and follow-up
with contrast-enhanced MRI. J Comput Assist
Tomogr 1996;20:512-21.
22. Dougados M, Gueguen A, Nakache JP, Velicitat
P, Veys EM, Zeidler H, et al. Ankylosing
spondylitis: what is the optimum duration of a
clinical study? A one year versus a 6 weeks non-
steroidal
anti-inflammatory
drug
trial.
Rheumatology (Oxford) 1999;38:235-44.
23. van der Heijde D, Baraf HS, Ramos-Remus C,
Calin A, Weaver AL, Schiff M, et al. Evaluation of
the efficacy of etoricoxib in ankylosing spondylitis:
results of a fifty-two-week, randomized, controlled
study. Arthritis Rheum 2005;52:1205-15.
24. Barkhuizen A, Steinfeld S, Robbins J, West C,
Coombs J, Zwillich S. Celecoxib is efficacious and
well tolerated in treating signs and symptoms of
ankylosing spondylitis. J Rheumatol 2006;33:1805-
12.